Dorling Janet

Director at CymaBay Therapeutics, Inc.; Chief Commercial Officer at Achaogen Inc

Sold, on record
$568k
Dollars the filings state
Form 4 sales
7
Latest Feb 12, 2024
Form 144 notices
4
Proposed sales
Companies
2
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale CymaBay Therapeutics, Inc.Routine
    Nov 10, 2023 2023

    Sold 7,000 shares at $15.24 ($107k)

    Dorling Janet, Director

    10b5-1 planSold 100% of holdings ($107k position)0 shares leftFirst sale on recordFiling

  2. 2 Form 144 notice CymaBay Therapeutics, Inc.Notice
    Nov 13, 2023 +3 days

    Filed to sell 7,000 shares ($107k)

    Dorling Janet, Director

    10b5-1 planFiling

  3. 3 Form 4 sale CymaBay Therapeutics, Inc.Routine
    Dec 11, 2023 +28 days

    Sold 6,000 shares at $20.07 ($120k)

    Dorling Janet, Director

    10b5-1 planSold 100% of holdings ($120k position)0 shares leftFollows a Form 144Filing

  4. 4 Form 144 notice CymaBay Therapeutics, Inc.Notice
    Dec 11, 2023 same day

    Filed to sell 6,000 shares ($120k)

    Dorling Janet, Director

    10b5-1 planFiling

  5. 5 Form 4 sale CymaBay Therapeutics, Inc.Routine
    Jan 10, 2024 +30 days

    Sold 6,000 shares at $23.86 ($143k)

    Dorling Janet, Director

    10b5-1 planSold 100% of holdings ($143k position)0 shares leftFollows a Form 144Filing

  6. 6 Form 144 notice CymaBay Therapeutics, Inc.Notice
    Jan 10, 2024 same day

    Filed to sell 6,000 shares ($143k)

    Dorling Janet, Director

    10b5-1 planFiling

  7. 7 Form 144 notice CymaBay Therapeutics, Inc.Notice
    Feb 12, 2024 +33 days

    Filed to sell 6,000 shares ($192k)

    Dorling Janet, Director

    10b5-1 plan1x usual sizeFiling

  8. 8 Form 4 sale CymaBay Therapeutics, Inc.Routine
    Feb 12, 2024 same day

    Sold 6,000 shares at $31.97 ($192k)

    Dorling Janet, Director

    10b5-1 planSold 100% of holdings ($192k position)0 shares left1x usual sizeFollows a Form 144Filing

Every transaction

Loading transactions…

Sales and notices (11)

Form 144 notices and Form 4 sales by Dorling Janet
Source
Feb 12, 2024Feb 14, 2024CymaBay Therapeutics, Inc.DirectorForm 4 sale6,000$192k100.0%RoutineSEC
Feb 12, 2024Feb 12, 2024CymaBay Therapeutics, Inc.DirectorForm 144 notice6,000$192kNoticeSEC
Jan 10, 2024Jan 10, 2024CymaBay Therapeutics, Inc.DirectorForm 144 notice6,000$143kNoticeSEC
Jan 10, 2024Jan 10, 2024CymaBay Therapeutics, Inc.DirectorForm 4 sale6,000$143k100.0%RoutineSEC
Dec 11, 2023Dec 11, 2023CymaBay Therapeutics, Inc.DirectorForm 144 notice6,000$120kNoticeSEC
Dec 11, 2023Dec 11, 2023CymaBay Therapeutics, Inc.DirectorForm 4 sale6,000$120k100.0%RoutineSEC
Nov 13, 2023Nov 13, 2023CymaBay Therapeutics, Inc.DirectorForm 144 notice7,000$107kNoticeSEC
Nov 10, 2023Nov 14, 2023CymaBay Therapeutics, Inc.DirectorForm 4 sale7,000$107k100.0%RoutineSEC
Feb 21, 2019Feb 25, 2019Achaogen IncChief Commercial OfficerForm 4 sale1,063$9460.4%Plan not statedSEC
Feb 5, 2019Feb 7, 2019Achaogen IncChief Commercial OfficerForm 4 sale818$1k0.3%Plan not statedSEC
Jun 26, 2018Jun 28, 2018Achaogen IncChief Commercial OfficerForm 4 sale450$4k1.9%Plan not statedSEC